Risultati di ricerca
Neil Weir. Chief Executive Officer. Neil was previously Senior Vice-President, Discovery, at UCB S.A., overseeing an integrated portfolio of small molecule and antibody therapeutic projects in the areas of immunology and neurology.
17 mag 2023 · Sitryx CEO, Neil Weir, presents at BioEquity Europe 2023. 17th May 2023. Sitryx CEO, Neil Weir, presents at BioEquity Europe 2023 on resetting the immune system in respiratory and dermatological disease.
Experience: Sitryx · Location: United Kingdom · 500+ connections on LinkedIn. View Neil Weir’s profile on LinkedIn, a professional community of 1 billion members.
- Sitryx
Neil Weir. Venture Partner. Neil joined SV as a Venture Partner in 2020. He is Chief Executive Officer of Sitryx Therapeutics, an SV-created company working in the field of immunometabolism to bring novel medicines to unmet needs in inflammation, autoimmunity and immuno-oncology.
Sitryx CEO, Neil Weir, comments on the new collaboration with Eli Lilly and Company, one of the global leaders in the field of #immunology. #immunometabolism #drugdiscovery
15 apr 2021 · Sitryx Therapeutics Neil Weir biopharmaceutical Iain Kilty immuno-oncology immunometabolism. http://www.sitryx.com. Sitryx further strengthens leadership team with the appointment of Iain...
24 mar 2021 · Neil Weir, Chief Executive Officer of Sitryx, said: “Pierre’s vast global experience in guiding companies through various stages of growth is unrivalled and his expertise in developing and...
